The concept and evolution of involved site radiation therapy for lymphoma
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605491429 | ||
| 003 | CHVBK | ||
| 005 | 20210128100510.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151001xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10147-015-0863-y |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10147-015-0863-y | ||
| 245 | 0 | 4 | |a The concept and evolution of involved site radiation therapy for lymphoma |h [Elektronische Daten] |c [Lena Specht, Joachim Yahalom] |
| 520 | 3 | |a We describe the development of radiation therapy for lymphoma from extended field radiotherapy of the past to modern conformal treatment with involved site radiation therapy based on advanced imaging, three-dimensional treatment planning and advanced treatment delivery techniques. Today, radiation therapy is part of the multimodality treatment of lymphoma, and the irradiated tissue volume is much smaller than before, leading to highly significant reductions in the risks of long-term complications. | |
| 540 | |a Japan Society of Clinical Oncology, 2015 | ||
| 690 | 7 | |a Lymphoma |2 nationallicence | |
| 690 | 7 | |a Radiation therapy |2 nationallicence | |
| 700 | 1 | |a Specht |D Lena |u Department of Oncology and Hematology, Section3994, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark |4 aut | |
| 700 | 1 | |a Yahalom |D Joachim |u Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA |4 aut | |
| 773 | 0 | |t International Journal of Clinical Oncology |d Springer Japan |g 20/5(2015-10-01), 849-854 |x 1341-9625 |q 20:5<849 |1 2015 |2 20 |o 10147 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10147-015-0863-y |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a review-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10147-015-0863-y |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Specht |D Lena |u Department of Oncology and Hematology, Section3994, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yahalom |D Joachim |u Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t International Journal of Clinical Oncology |d Springer Japan |g 20/5(2015-10-01), 849-854 |x 1341-9625 |q 20:5<849 |1 2015 |2 20 |o 10147 | ||